Analyst picks & changes

The Liposome Co. Inc.


Liposome Technology Inc.


NeXstar Inc.


Based on a comparison of the three companies' lipid-based amphotericin B products to treat fungal infections, UBS Securities analyst Marc Ostro said that he expects LIPO's

Read the full 388 word article

How to gain access

Continue reading with a
two-week free trial.